Hamilton AD - Search Results

1

Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on ras in human hepatic stellate cells.

Carloni V, Pinzani M, Giusti S, Romanelli RG, Parola M, Bellomo G, Failli P, Hamilton AD, Sebti SM, Laffi G, Gentilini P. Carloni V, et al. Among authors: hamilton ad. Hepatology. 2000 Jan;31(1):131-40. doi: 10.1002/hep.510310121. Hepatology. 2000. PMID: 10613738

2

Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines.

Mazzocca A, Giusti S, Hamilton AD, Sebti SM, Pantaleo P, Carloni V. Mazzocca A, et al. Among authors: hamilton ad. Mol Pharmacol. 2003 Jan;63(1):159-66. doi: 10.1124/mol.63.1.159. Mol Pharmacol. 2003. PMID: 12488548

3

Inhibition of Ras prenylation: a novel approach to cancer chemotherapy.

Sebti SM, Hamilton AD. Sebti SM, et al. Among authors: hamilton ad. Pharmacol Ther. 1997;74(1):103-14. doi: 10.1016/s0163-7258(97)00014-4. Pharmacol Ther. 1997. PMID: 9336018 Review.

4

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues.

Sebti SM, Hamilton AD. Sebti SM, et al. Among authors: hamilton ad. Expert Opin Investig Drugs. 2000 Dec;9(12):2767-82. doi: 10.1517/13543784.9.12.2767. Expert Opin Investig Drugs. 2000. PMID: 11093352 Review.

5

Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor.

Lerner EC, Qian Y, Hamilton AD, Sebti SM. Lerner EC, et al. Among authors: hamilton ad. J Biol Chem. 1995 Nov 10;270(45):26770-3. doi: 10.1074/jbc.270.45.26770. J Biol Chem. 1995. PMID: 7592913 Free article.

6

Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion.

Sun J, Qian Y, Hamilton AD, Sebti SM. Sun J, et al. Among authors: hamilton ad. Cancer Res. 1995 Oct 1;55(19):4243-7. Cancer Res. 1995. PMID: 7671229

7

Rational design of Ras prenyltransferase inhibitors as potential anticancer drugs.

Sebti SM, Hamilton AD. Sebti SM, et al. Among authors: hamilton ad. Biochem Soc Trans. 1996 Aug;24(3):692-9. doi: 10.1042/bst0240692. Biochem Soc Trans. 1996. PMID: 8878828 Review. No abstract available.

8

Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation.

McGuire TF, Qian Y, Vogt A, Hamilton AD, Sebti SM. McGuire TF, et al. Among authors: hamilton ad. J Biol Chem. 1996 Nov 1;271(44):27402-7. doi: 10.1074/jbc.271.44.27402. J Biol Chem. 1996. PMID: 8910319 Free article.

9

Farnesyltransferase as a target for anticancer drug design.

Qian Y, Sebti SM, Hamilton AD. Qian Y, et al. Among authors: hamilton ad. Biopolymers. 1997;43(1):25-41. doi: 10.1002/(SICI)1097-0282(1997)43:1<25::AID-BIP4>3.0.CO;2-2. Biopolymers. 1997. PMID: 9174410 Review.

10

Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.

Lerner EC, Hamilton AD, Sebti SM. Lerner EC, et al. Among authors: hamilton ad. Anticancer Drug Des. 1997 Jun;12(4):229-38. Anticancer Drug Des. 1997. PMID: 9199657 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters